While a large body of evidence indicates that PTHrP has deleterious effects during late stages of breast cancer by promoting bone metastasis, tumor-induced osteolysis, and exit from dormancy, PTHrP’s role early in disease progression is highly controversial [27, 28, 32, 46, 47]. This evidence concerns the gene PTHLH and breast cancer.